ClinicalTrials.Veeva

Menu

Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Deformational Plagiocephaly
Congenital Muscular Torticollis
Brachycephaly
Deformational Posterior Plagiocephaly
Torticollis

Treatments

Device: Cranial Remolding Orthosis
Other: Repositioning Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05917678
STU 032017-036

Details and patient eligibility

About

This study will examine how effective caregiver's repositioning strategies are in correcting an infant's deformational cranial shape, as well as the effectiveness of the use of a custom cranial remolding orthosis for treatment of deformational head shapes. Infants with torticollis will be concurrently enrolled in physical therapy treatment until the torticollis is resolved. A normal, unaffected population will be studied to compare typical growth to the growth of infants undergoing active treatment.

Full description

Infants 2 months of age who have been diagnosed with a deformational head shape will be begin repositioning therapy (and physical therapy if torticollis is present) and be followed at least monthly. At 4, 5, and 6 months of age, if the head shape has not resolved, they will be given the option to pursue treatment with a cranial remolding orthosis. All affected infants will undergo active treatment until the head shape is resolved or the infant is 12 months of age (whichever comes first).

Normal infants will be evaluated at 2, 6, and 12 months of age and will not be enrolled in any active treatment.

All infants will return at 12 months of age for a final evaluation.

Enrollment

65 estimated patients

Sex

All

Ages

2 to 3 months old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Control Group:

  • Healthy infants with normal physical development and no need for physical therapy intervention

Exclusion Criteria for Control Group:

  • Infants with abnormal head shapes (plagiocephaly or craniosynostosis)
  • Infants with growth abnormalities (such as genetic conditions)
  • Infants with developmental delay significant to warrant physical therapy or occupational therapy

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

65 participants in 3 patient groups

Repositioning Therapy
Other group
Description:
Infants will be treated with at-home repositioning strategies for their deformational head shape. Physical therapy will be provided, if indicated, for treatment of torticollis. This is a standard treatment.
Treatment:
Other: Repositioning Therapy
Repositioning Therapy + Cranial Remolding Orthoses
Other group
Description:
After attempting at 2-4 months of repositioning therapy, infants with residual cranial deformation may be treated with a custom made helmet (cranial remolding orthosis) which is adjusted every few weeks to direct skull growth. It is worn 23 hours per day. Physical therapy will be provided, if indicated, for treatment of torticollis. This is a standard treatment.
Treatment:
Other: Repositioning Therapy
Device: Cranial Remolding Orthosis
Control
No Intervention group
Description:
Healthy infants without deformational head shapes or need for physical therapy will be followed and measured. No intervention.

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Tiffany Graham, MSPO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems